CD4 and urinary bladder cancer: Since CD4+ Treg frequency was found to be increased both in the circulation and at the tumor site in bladder cancer patients, as compared to what was observed in renal cancer patients, it is likely that both the mechanisms of CD4+ Treg in situ generation (at the tumor site) and recruitment from the periphery could be at play in bladder cancer patients.